Leadless Pacemaker Coordination for Arrhythmia Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems for treating cardiac arrhythmias often require multiple devices and lack efficient coordination between different therapies, such as anti-tachycardia pacing (ATP) and defibrillation shock therapy, which can lead to suboptimal treatment outcomes.
Innovation Solution
A medical device system comprising a leadless cardiac pacemaker (LCP) and another medical device that are communicatively coupled to coordinate and modify therapy delivery, where the LCP determines arrhythmias and communicates to adjust the defibrillation shock therapy, potentially suspending or altering the treatment based on susceptibility to ATP therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multiple devices are used to treat cardiac arrhythmias, then therapy coverage is improved, but device coordination and treatment effectiveness deteriorate due to lack of efficient coordination between different therapies
Solution Approach 1:
The patent combines multiple therapy functions (ATP and defibrillation) into a coordinated system where the LCP and medical device work together as an integrated unit. The LCP determines arrhythmia occurrences and communicates with the medical device to coordinate therapy delivery, merging the capabilities of separate devices into a unified treatment approach that improves both coverage and effectiveness.
Solution Approach 2:
The system implements feedback mechanisms where the LCP monitors arrhythmia occurrences and communicates this information to the medical device. The medical device receives information about arrhythmia susceptibility to ATP therapy and adjusts defibrillation shock therapy accordingly. This feedback loop enables dynamic coordination between devices, ensuring that therapy delivery is optimized based on real-time physiological conditions.
2Speed
If defibrillation shock therapy is delivered independently without coordination, then response time is improved, but treatment precision deteriorates due to inability to modify therapy based on ATP susceptibility
Solution Approach 1:
The LCP performs preliminary assessment of arrhythmia susceptibility to ATP therapy before the medical device delivers defibrillation shock therapy. By determining ATP susceptibility in advance, the system can prepare appropriate therapy modifications, ensuring that when defibrillation is needed, it is delivered with precise coordination and optimal parameters based on the preliminary assessment.
Solution Approach 2:
The system dynamically adjusts defibrillation shock therapy parameters based on real-time communication between the LCP and medical device. The LCP can modify the amplitude, timing, or delivery of defibrillation pulses based on the specific arrhythmia characteristics and ATP susceptibility assessment. This dynamic adjustment capability maintains fast response time while achieving high treatment precision through adaptive therapy modification.
3Reliability
If the LCP modifies defibrillation shock therapy based on ATP susceptibility, then treatment effectiveness is improved, but device complexity increases due to communication and coordination requirements
Solution Approach 1:
The LCP is designed with multi-functionality, serving both as a pacemaker and as an arrhythmia monitoring device that communicates with the medical device. The medical device also performs multiple functions including defibrillation delivery and receiving modification commands from the LCP. This universal design reduces the need for separate specialized devices, managing complexity through consolidation while maintaining effective coordination.
Solution Approach 2:
The communication interface between the LCP and medical device acts as an intermediary that manages the coordination complexity. The LCP sends arrhythmia occurrence information and ATP susceptibility assessments to the medical device, which then translates these into appropriate defibrillation therapy modifications. This intermediary communication layer simplifies the interaction between devices, managing complexity through standardized information exchange protocols.
4Measurement precision
If real-time modification of defibrillation shock therapy is implemented, then therapy precision is improved, but energy consumption increases due to continuous monitoring and communication
Solution Approach 1:
The LCP monitors arrhythmia occurrences and communicates with the medical device at periodic intervals based on physiological events rather than continuously. Therapy modification commands are transmitted only when relevant arrhythmia events occur or when ATP susceptibility assessments are completed. This periodic action approach maintains high therapy precision through timely communication while significantly reducing energy consumption compared to continuous monitoring and transmission.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system enables more precise and coordinated delivery of electrical stimulation therapies, improving the effectiveness in treating cardiac arrhythmias by determining the appropriateness of ATP therapy and modifying defibrillation shock therapy in real-time.
Implementation Method 1
the LCP may determine an occurrence of a cardiac arrhythmia based, at least in part, on one or more received physiological signals or indications of one or more physiological conditions of the patient. the one or more received physiological signals may comprise one or more of: cardiac electrical activity; contractility of the heart of the patient; cardiac output of the heart of the patient; and hearts sounds.
Implementation Method 2
the defibrillation shock therapy may comprise, after the medical device determines an occurrence of a cardiac arrhythmia: charging a capacitor to a predefined level; and after charging the capacitor to the predefined level, delivering one or more defibrillation pulses to the heart of the patient using at least some energy stored in the capacitor.
Data Source
AI summary
Systems and methods for treating cardiac arrhythmias. One example medical device system for delivering electrical stimulation therapy to a heart of a patient may comprise a leadless cardiac pacemaker (LCP) implanted within a heart of a patient and configured to determine occurrences of cardiac arrhythmias, a medical device configured to determine occurrences of cardiac arrhythmias and to deliver defibrillation shock therapy to the patient, wherein the LCP and the medical device are spaced from one another and communicatively coupled, and wherein after the LCP determines an occurrence of a cardiac arrhythmia, the LCP is configured to modify the defibrillation shock therapy of the medical device.